Ferro-Alloy Resources: Vanadium Giant Unveils Feasibility Win and Massive Phase Two Upside (Video) 14 October 2025
Diverse Income Trust beats key benchmarks, Gervais shares portfolio insights (LON:DIVI) 14 October 2025
Thor Explorations strong cash flow, profits and management execution impresses Gervais Williams (LON:THX) 13 October 2025
Atalaya Mining “superbly positioned” for rising demand and profits highlights fund manager (LON:ATYM) 13 October 2025
Record plc services becoming “much more valuable” explains upbeat DIVI fund manager (LON:REC) 13 October 2025
Why Real Estate Credit Investments’ Resilience Could Be an Investor’s Hidden Advantage (Video) 13 October 2025
AstraZeneca’s Tezspire recommended for EU approval in chronic rhinosinusitis with nasal polyps 22 September 2025
Baillie Gifford US Growth Trust (USA.L) Stock Analysis: Navigating the Investment Landscape with a $748 Million Trust 14 October 2025
Assura PLC (AGR.L) Stock Analysis: A Reliable Dividend Payer with Growth Potential in Healthcare Real Estate 14 October 2025
Bankers Investment Trust Plc (BNKR.L) Rating Update: Navigating Market Trends with Robust Technical Indicators 14 October 2025
Hilton Food Group (HFG.L): Exploring 50% Potential Upside Through Strategic Global Expansion 14 October 2025
Ferro-Alloy Resources: Vanadium Giant Unveils Feasibility Win and Massive Phase Two Upside (Video) 14 October 2025
Diverse Income Trust beats key benchmarks, Gervais shares portfolio insights (LON:DIVI) 14 October 2025
Thor Explorations strong cash flow, profits and management execution impresses Gervais Williams (LON:THX) 13 October 2025
Atalaya Mining “superbly positioned” for rising demand and profits highlights fund manager (LON:ATYM) 13 October 2025
Record plc services becoming “much more valuable” explains upbeat DIVI fund manager (LON:REC) 13 October 2025
Why Real Estate Credit Investments’ Resilience Could Be an Investor’s Hidden Advantage (Video) 13 October 2025
AstraZeneca’s Tezspire recommended for EU approval in chronic rhinosinusitis with nasal polyps 22 September 2025
Baillie Gifford US Growth Trust (USA.L) Stock Analysis: Navigating the Investment Landscape with a $748 Million Trust 14 October 2025
Assura PLC (AGR.L) Stock Analysis: A Reliable Dividend Payer with Growth Potential in Healthcare Real Estate 14 October 2025
Bankers Investment Trust Plc (BNKR.L) Rating Update: Navigating Market Trends with Robust Technical Indicators 14 October 2025
Hilton Food Group (HFG.L): Exploring 50% Potential Upside Through Strategic Global Expansion 14 October 2025
Senseonics Holdings, Inc. (SENS) Stock Analysis: Exploring a 192.93% Upside Potential in the Medical Device Sector 14 August 2025
Fulcrum Therapeutics, Inc. (FULC) Stock Analysis: Exploring a 61.63% Potential Upside in the Biotech Sector 14 August 2025
Entrada Therapeutics, Inc. (TRDA) Stock Analysis: Exploring a Biotech Gem with a 247% Upside Potential 14 August 2025
NetClass Technology Inc (NTCL) Stock Analysis: Navigating Volatility with Emerging Opportunities in the EdTech Sector 14 August 2025
ZoomInfo Technologies Inc. (GTM) Stock Analysis: Navigating a 15.49% Potential Upside in a Competitive Software Landscape 14 August 2025
ServiceTitan, Inc. (TTAN) Stock Analysis: 23.64% Potential Upside and Strong Buy Ratings Highlight Investment Appeal 14 August 2025
Health Catalyst, Inc. (HCAT) Stock Analysis: Analyzing a 65.63% Potential Upside in Health Information Services 14 August 2025
SoundHound AI, Inc. (SOUN) Stock Analysis: Unpacking the 217% Revenue Growth Amid Market Challenges 14 August 2025
A2Z Cust2Mate Solutions Corp. (AZ) Investor Outlook: Exploring a 103.67% Potential Upside 14 August 2025
Abeona Therapeutics Inc. (ABEO): Analyst Consensus Highlights a 203.79% Upside Potential 14 August 2025
Cytek Biosciences, Inc. (CTKB) Stock Analysis: Exploring a 22.9% Potential Upside in the Healthcare Sector 14 August 2025
Neuronetics, Inc. (STIM) Stock Analysis: A 67.96% Potential Upside in the Healthcare Sector 14 August 2025
Tvardi Therapeutics, Inc. (TVRD) Investor Outlook: Exploring a Promising 137.69% Upside 14 August 2025
Phathom Pharmaceuticals, Inc. (PHAT) Stock Analysis: Exploring a 95.61% Potential Upside with Strong Buy Ratings 14 August 2025
Candel Therapeutics, Inc. (CADL) Stock Analysis: A Biotech Gem with 228% Potential Upside 14 August 2025
Immutep Limited (IMMP) Stock Analysis: A High-Risk, High-Reward Biotech Play with a 449% Potential Upside 14 August 2025
Palvella Therapeutics, Inc. (PVLA) Stock Analysis: A Biotech Contender with 20% Upside Potential 14 August 2025
Absci Corporation (ABSI) Stock Analysis: A Biotech Innovator with 167% Upside Potential 14 August 2025
Genuit acquires Davidson Holdings for £49m to expand plumbing and heating portfolio 29 September 2025
Diverse Income Trust beats key benchmarks, Gervais shares portfolio insights (LON:DIVI) 14 October 2025
Thor Explorations strong cash flow, profits and management execution impresses Gervais Williams (LON:THX) 13 October 2025
Atalaya Mining “superbly positioned” for rising demand and profits highlights fund manager (LON:ATYM) 13 October 2025
Record plc services becoming “much more valuable” explains upbeat DIVI fund manager (LON:REC) 13 October 2025
Why Real Estate Credit Investments’ Resilience Could Be an Investor’s Hidden Advantage (Video) 13 October 2025
Ferro-Alloy Resources: Vanadium Giant Unveils Feasibility Win and Massive Phase Two Upside (Video) 14 October 2025
Baillie Gifford US Growth Trust (USA.L) Stock Analysis: Navigating the Investment Landscape with a $748 Million Trust 14 October 2025
Assura PLC (AGR.L) Stock Analysis: A Reliable Dividend Payer with Growth Potential in Healthcare Real Estate 14 October 2025
Bankers Investment Trust Plc (BNKR.L) Rating Update: Navigating Market Trends with Robust Technical Indicators 14 October 2025
Hilton Food Group (HFG.L): Exploring 50% Potential Upside Through Strategic Global Expansion 14 October 2025
